Correlation Between Placental Thickness in the Second and Third Trimester and Fetal Weight
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02473991 |
|
Recruitment Status :
Completed
First Posted : June 17, 2015
Results First Posted : August 2, 2017
Last Update Posted : August 2, 2017
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Pregnancy Fetal Macrosomia Intrauterine Growth Restriction | Radiation: ultrasound |
The investigator will make certain that the appropriate informed consent process is in place to ensure that potential research subjects, or their authorized representatives, are fully informed about the nature and objectives of the study, the potential risk and benefits of study participation, and their right as research subjects.
All laboratory specimens, evaluation forms, reports, video recordings, and other records that leave the site will not include unique personal data to maintain subject confidentiality.
All patients provided an informed written consent after they were fully instructed about the investigation.The study was approved by ethical committee of Ain Shams University.
All recruited women were observed at the 1st trimester screening at antenatal clinic and assessed for baseline demographic and obstetric data including age, parity, body mass index (BMI) and past medical events. Smoking, alcohol and drug use were also determined.
At second and third trimester (15-20 and 30-34 weeks of gestation respectively), the maternal weight, weight gain, BMI, BMI gain and data of ultrasound examination were recorded. At the time of delivery after assessment of maternal weight as mentioned above, the birth weight (in grams), fetal sex, and mode of delivery were taken.
All pregnant women underwent ultrasound evaluation of placental thickness at the time of second trimester (15-20 weeks of gestation) as well as third trimester (30-34 weeks of gestation).
All sonographic examinations were performed trans-abdominal using a Medison X4 ultrasound machine Trans abdominal4.0 megahertz (MHz) probe at The Special Care Center for Fetus Unit at Ain Shams University Maternity Hospital.
The placental thickness was measured by placing the ultrasound transducer perpendicularly to the plane of the placenta, in the area of the cord insertion, near the mid-placental portion as described by Hoddick et al
Each evaluation was performed by one of two experienced sonographers of our hospital with minimum inter- and intra-observer variability.
After delivery, the placenta was weighed in grams as previously described by Azpurua et al.
Fetal weight (primary objective) and neonatal status and morbidity including baby Apgar scores, fetal distress or fetal death and admission to the neonatal intensive care unit were also determined. All the examinations and data recording were performed by two senior resident physicians.(secondary objective)
| Study Type : | Observational |
| Actual Enrollment : | 395 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Correlation Between Placental Thickness in the Second and Third Trimester and Fetal Weight |
| Study Start Date : | March 2015 |
| Actual Primary Completion Date : | December 2016 |
| Actual Study Completion Date : | January 2017 |
- Radiation: ultrasound
The placental thickness was measured by placing the ultrasound transducer perpendicularly to the plane of the placenta, in the area of the cord insertion, near the mid-placental portion
- Fetal Weight (Fetal Weight at Birth) [ Time Frame: 9 months ]Fetal weight (fetal weight at birth) (in grams)
- Placental Thickness in Second Trimester [ Time Frame: 15-20 weeks of gestation ]placental thickness measured in millimeter
- Placental Thickness at 3rd Trimester [ Time Frame: 30-34 weeks of pregnancy ]
Biospecimen Retention: Samples Without DNA
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years to 30 Years (Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- patient Aged between 18 and 45 years.
- singleton viable pregnancy.
- non scared uterus.
Exclusion Criteria:
- systemic illness (DM,Hypertension, renal disease, liver disease, sickle cell disease)
- known congenital fetal anomalies.
- multiple pregnancy.
- intra uterine fetal death.
- anatomical defect of pregnant uterus
- abnormally located placenta or placental anomalies
- morbid obesity
- missing records
- unwilling to incorporate in the study.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02473991
| Egypt | |
| Ain shams faculty of medicine | |
| Cairo, Elabbasia, Egypt | |
| Study Director: | AHMED MEKLED, Professor | Ain Shams University | |
| Study Director: | HAYTHAM SABAA, Lecturer | Ain Shams University |
| Responsible Party: | amr elsayed elsayed, researcher for master degree, Ain Shams Maternity Hospital |
| ClinicalTrials.gov Identifier: | NCT02473991 |
| Other Study ID Numbers: |
Master degree in Obs & gyn |
| First Posted: | June 17, 2015 Key Record Dates |
| Results First Posted: | August 2, 2017 |
| Last Update Posted: | August 2, 2017 |
| Last Verified: | April 2017 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
|
Fetal Growth Retardation Fetal Macrosomia Fetal Weight Fetal Diseases Pregnancy Complications Growth Disorders Pathologic Processes |
Diabetes, Gestational Pregnancy in Diabetics Diabetes Complications Diabetes Mellitus Endocrine System Diseases Birth Weight Body Weight |

